Rekah Pharmaceutical Industry Ltd (REKA) — Cash Flow Quality Index
Rekah Pharmaceutical Industry Ltd (REKA) has a Cash Flow Quality Index of 1.19x as of June 2024. Operating cash flow of ILA14.31 Million exceeds net income of ILA12.00 Million, indicating high earnings quality where cash backs reported profits. Explore long-term investment intensity of Rekah Pharmaceutical Industry Ltd to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Rekah Pharmaceutical Industry Ltd Cash Flow Quality Index (2004–2024)
Historical Cash Flow Quality Index for Rekah Pharmaceutical Industry Ltd across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check REKA tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Rekah Pharmaceutical Industry Ltd (2004–2024)
Year-by-year earnings quality comparison for Rekah Pharmaceutical Industry Ltd. For live market cap and the full company financial profile, see market cap of Rekah Pharmaceutical Industry Ltd.
| Year | Quality Index | Operating CF (ILA) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 4.28x | ILA26.54 Million | ILA6.21 Million | ▲ +33.6% |
| 2021 | 3.20x | ILA21.17 Million | ILA6.61 Million | ▲ +206.3% |
| 2020 | 1.05x | ILA11.28 Million | ILA10.80 Million | ▼ -88.1% |
| 2019 | 8.78x | ILA33.91 Million | ILA3.86 Million | ▲ +246.8% |
| 2018 | 2.53x | ILA17.28 Million | ILA6.83 Million | ▲ +81.4% |
| 2013 | 1.40x | ILA11.71 Million | ILA8.39 Million | ▼ -27.2% |
| 2012 | 1.92x | ILA14.18 Million | ILA7.40 Million | ▼ -89.0% |
| 2010 | 17.45x | ILA6.73 Million | ILA386.00K | ▲ +244.8% |
| 2009 | 5.06x | ILA26.03 Million | ILA5.14 Million | ▲ +80.1% |
| 2007 | 2.81x | ILA12.45 Million | ILA4.43 Million | ▲ +324.2% |
| 2005 | 0.66x | ILA4.27 Million | ILA6.45 Million | ▼ -67.3% |
| 2004 | 2.03x | ILA17.87 Million | ILA8.82 Million | — |